SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cardiologist to be who wrote (1083)3/16/1998 10:44:00 AM
From: KurtVedder  Read Replies (1) of 1359
 
FWIW I spoke with one of the cardiologist's in my family regarding the studies
that are being conducted in his hospital (Tulane)-he stated that there has been NO abnormalities in the Redux patients as of yet. They are considering stopping the study due to the
fact that they feel it is a "waste of time". In addition, he claims he heard info regarding the Harvard study that has, in his words, leaked out. He says the studies show, in his words, "NOTHING". He told me to relax. He feels that info will come out at the big ACC (Cardiology) conference in Atlanta at the end of March. He tells me that the general consensus among cardiologist's is that this is way overblown. We shall see. Take it all with a grain of salt, but I
believe that buying IPIC is a good bet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News